Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections
Access

76 - 100 of 236 Items

Original paper2023, aug 8

Ultrasound characteristics of the cervical vagus nerve in patients with type 2 diabetes and diabetic peripheral neuropathy

Fan Xiong, Qian Wang, Yun Hu, Xiao Jiang, Lin Liu, Yumeng Han, Qing Jiang, Shiqin Yuan, Lan Xu

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577998
Endokrynol Pol 2023;74(4):421-429.
Letter to the Editor2023, jul 27
Original paper2023, jul 27

Previous, simultaneous, or subsequent occurrence of malignant tumours in patients with primary hyperparathyroidism: a closer look at the single-tertiary-centre cases

Havva Sezer, Hande Bulut Canbaz, Serdar Tezelman, Tarık Terzioğlu, Eda Nur Çilingiroğlu, Bülent Çolakoğlu, Dilek Yazıcı, Oğuzhan Deyneli, Mehmet Onur Demirkol, Adnan Batman, Seçil Özışık, Yersu Yapran, Faruk Alagöl

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577997
Endokrynol Pol 2023;74(4):372-379.
Original paper2023, jul 27

Clinical value of miR-23a-3p expression in early diagnosis of diabetic kidney disease

Xiaomei Meng, Xiao Yu, Peipei Lei

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577996
Endokrynol Pol 2023;74(4):414-420.
Original paper2023, jul 27

A comparison of the 2 thermal ablation procedures for the management of benign thyroid nodules

Süleyman Sönmez, Elif Önder, Mehtap Navdar Başaran, Hatice Çalışkan, Yıldıray Topçu, Sevcan Genç, Hande Peynirci

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577995
Endokrynol Pol 2023;74(4):392-397.
Original paper2023, jul 21

The value of [18F]FDG PET/CT in avoiding overtreatment of 131l avidity pulmonary metastasis of differentiated thyroid cancer

Zhongyun Xu, Chao Li, Fang Feng, Shuqi Wu, Hui Wang, Hongliang Fu

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577994
Endokrynol Pol 2023;74(4):385-391.
Original paper2023, jul 21

Hyperandrogenism-related metabolic changes in drug-naïve transmen compared to cisgender women: a case-controlled study

Pınar Erel, Onur Elbasan, Neşe Yorguner, Eren İmre, Özlem Üstay

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577993
Endokrynol Pol 2023;74(4):398-403.
Clinical vignette2023, jul 18

Difficulties in achieving euthyroid status in a patient with differentiated thyroid cancer after sleeve gastrectomy

Adam Daniel Durma, Marek Saracyn, Anna Celina Durma, Grzegorz Kamiński

Vol 74, No 4 (2023)

Clinical vignette

Pubmed: 37578001
Endokrynol Pol 2023;74(4):439-440.
Clinical vignette2023, jul 18

Lethargic patient with hepatocirrhosis — more than meets the eye

Mateusz Maligłówka, Aleksandra Sojka, Anna Bartecka, Łukasz Bułdak, Bogusław Okopien

Vol 74, No 4 (2023)

Clinical vignette

Pubmed: 37578000
Endokrynol Pol 2023;74(4):443-444.
Original paper2023, jul 18

Functional status as a predictor of the incidence of falls in 10-year follow-up: results from the RAC-OST-POL study

Wojciech Pluskiewicz, Piotr Adamczyk, Bogna Drozdzowska

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577992
Endokrynol Pol 2023;74(4):404-407.
Original paper2023, jul 18

Evaluation of pulmonary side effects in prolactinoma patients treated with cabergoline

Ozlem Soyluk, Zuleyha Bingol, Sema Ciftci, Neslihan Kurtulmus, Seher Tanrikulu, Sema Yarman

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577991
Endokrynol Pol 2023;74(4):380-384.
Original paper2023, jul 11

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas

Marta Opalińska, Aleksandra Gilis-Januszewska, Karolina Morawiec-Sławek, Anna Kurzyńska, Anna Sowa-Staszczak, Anna Bogusławska, Ewelina Rzepka, Alicja Hubalewska-Dydejczyk

Vol 74, No 4 (2023)

Original paper

Pubmed: 37431872
Endokrynol Pol 2023;74(4):363-371.
Review paper2023, jun 30

The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes

Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Krzysztof Irlik, Oliwia Janota, Hanna Kwiendacz, Paulina Szromek-Białek, Mirosław Maziarz, Tomasz Stompór, Janusz Gumprecht, Gregory Y. H. Lip

Vol 74, No 4 (2023)

Review paper

Pubmed: 37431873
Endokrynol Pol 2023;74(4):349-362.
Clinical vignette2023, jun 26

Diagnostic and therapeutic difficulties in a patient with corticotropic pituitary macroadenoma

Grzegorz Erbert, Elżbieta Łomna-Bogdanov, Marek Bolanowski

Vol 74, No 4 (2023)

Clinical vignette

Pubmed: 37431874
Endokrynol Pol 2023;74(4):437-438.
Original paper2023, jun 21

Osteoporosis treatment with denosumab in routine clinical practice in Poland

Ewa Marcinowska-Suchowierska, Tomasz Blicharski, Ewa Wielosz, Maria Rell-Bakalarska, Krzysztof Duma, Katarzyna Paradowska-Kowal, Ewa Sewerynek

Vol 74, No 3 (2023)

Original paper

Pubmed: 37695033
Endokrynol Pol 2023;74(3):243-253.
Original paper2023, jun 21

Bioinformatics analysis of CUL2/4A/9 and its function in head and neck squamous cell carcinoma

Bingqing Xu, Ruohuang Wang, Jisheng Zhang, Lin Wang, Xin Cui, Fangyu Chai, Xiaoyun Du, Yan Jiang

Vol 74, No 3 (2023)

Original paper

Pubmed: 37695034
Endokrynol Pol 2023;74(3):315-330.
Clinical vignette2023, jun 21

Progression of a corticotroph tumour during durable medical therapy with osilodrostat in a patient with persistent Cushing’s disease

Bartłomiej Borawski, Agnieszka Wojciechowska-Luźniak, Grzegorz Zieliński, Przemysław Witek

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37695035
Endokrynol Pol 2023;74(3):346-347.
Original paper2023, jun 20

Association between TSH suppression therapy and type 2 deiodinase gene polymorphism in differentiated thyroid carcinoma

Xiaoke Zheng, Lichang Zhong, Tianjiao Zhou, Feng Zhao, Bin Chen

Vol 74, No 4 (2023)

Original paper

Pubmed: 37431871
Endokrynol Pol 2023;74(4):408-413.
Review paper2023, jun 12

Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials

Haibing Dai, Yonglin Zhu, Zuyi Chen, Renqing Yan, Jinsong Liu, Ziyun He, Lin Zhang, Feng Zhang, Shengkai Yan

Vol 74, No 3 (2023)

Review paper

Pubmed: 37335067
Endokrynol Pol 2023;74(3):234-242.
Original paper2023, jun 12

Demographics, practice patterns, job satisfaction, and career plans of endocrinologists in Poland

Wojciech S. Zgliczyński, Adam Skowron

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335066
Endokrynol Pol 2023;74(3):331-339.
Original paper2023, jun 12

The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome

Anna Świąder-Leśniak, Dorota Jurkiewicz, Honorata Kołodziejczyk, Agata Kozłowska, Alicja Korpysz, Mieczysław Szalecki, Krystyna Chrzanowska

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335065
Endokrynol Pol 2023;74(3):285-293.
Clinical vignette2023, jun 12

COVID-19 infection in a patient with Cushing’s disease on osilodrostat treatment

Anna Bogusławska, Mari Minasyan, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37335068
Endokrynol Pol 2023;74(3):342-343.
Original paper2023, may 29
Original paper2023, may 15

Irisin attenuates pyroptosis in high glucose-induced pancreatic beta cells via the miR-133a-3p/FOXO1 axis

Anjun Tan, Tianrong Li, Jingjing Yang, Jinwen Yu, Hewen Chen

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335063
Endokrynol Pol 2023;74(3):277-284.
Review paper2023, may 9

The influence of various endocrine disruptors on the reproductive system

Agata Czarnywojtek, Magdalena Borowska, Kamil Dyrka, Jakub Moskal, Jeremi Kościński, Iwona Krela-Kaźmierczak, Agnieszka Marta Lewandowska, Boushra Abou Hjeily, Paweł Gut, Karolina Hoffmann, Stefaan Van Gool, Nadia Sawicka-Gutaj, Marek Ruchała

Vol 74, No 3 (2023)

Review paper

Pubmed: 37695032
Endokrynol Pol 2023;74(3):221-233.